Skip to main content

Leonteq Securities AG

Broker-Dealer

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1535950 ZURICH, V8

Position in TEVA

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$185,147
+$120,043 QoQ
Shares Held
6,147
+194.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Dec 31, 2022
CallValue
$1,875,984
CallShares
205,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Leonteq Securities AG holds $3,761,723 across 15 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 TEVA
Teva Pharmaceutical Industries Ltd
This page
6,147 $185,147

All Filings in TEVA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $185,147 6,147
2025-12-31 $65,104 2,086
2025-09-30 $296,657 14,686
2025-06-30 $570,426 34,035
2025-03-31 $1,184,980 77,097
2024-12-31 $25,037 1,136
2024-09-30 $25,336 1,406
2024-06-30 $80,275 4,940
2024-03-31 $771,210 54,657
2023-12-31 $2,927,657 280,427
2023-09-30 $3,337,144 327,171
2023-06-30 $3,012,986 400,131
2023-03-31 $2,530,312 285,911
2022-12-31 $1,875,984 205,700
2022-09-30 $256,319 31,762
2022-06-30 $968,764 128,825
2022-03-31 $2,082,298 221,757
2021-12-31 $1,660,200 207,266
2021-09-30 $2,748,628 282,200
2021-06-30 $1,032,540 104,297
2021-03-31 $747,618 64,785
2020-12-31 $1,196,899 124,031
2020-12-31 $2,026,500 210,000